US Stock MarketDetailed Quotes

Eledon Pharmaceuticals (ELDN)

Watchlist
  • 3.200
  • -0.020-0.62%
Close Apr 14 16:00 ET
  • 3.230
  • +0.030+0.94%
Post 19:09 ET
242.73MMarket Cap-6.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Eledon Pharmaceuticals (ELDN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
17.96%83.25M
-13.01%21.48M
-7.02%19.07M
70.55%24.73M
65.28%17.96M
64.13%70.58M
138.89%24.7M
83.16%20.51M
40.06%14.5M
-2.17%10.87M
Selling and administrative expenses
-8.75%16.98M
-41.00%3.99M
2.78%4.1M
1.39%4.46M
28.16%4.43M
46.70%18.61M
106.91%6.77M
22.13%3.99M
39.42%4.4M
15.42%3.46M
-General and administrative expense
-8.75%16.98M
-41.00%3.99M
2.78%4.1M
1.39%4.46M
28.16%4.43M
46.70%18.61M
106.91%6.77M
22.13%3.99M
39.42%4.4M
15.42%3.46M
Research and development costs
27.52%66.27M
-2.44%17.49M
-9.39%14.97M
100.63%20.28M
82.60%13.53M
71.43%51.96M
153.69%17.93M
108.30%16.52M
40.34%10.11M
-8.67%7.41M
Operating profit
-17.96%-83.25M
13.01%-21.48M
7.02%-19.07M
-70.55%-24.73M
-65.28%-17.96M
-64.13%-70.58M
-138.89%-24.7M
-83.16%-20.51M
-40.06%-14.5M
2.17%-10.87M
Net non-operating interest income expense
Other net income (expense)
8.17%37.67M
156.81%11.07M
-98.35%1.61M
144.46%13.52M
189.87%11.47M
147.36%34.82M
1.37%-19.49M
7,444.97%97.48M
45.12%-30.41M
-3,875.74%-12.76M
Gain on sale of security
8.25%33.45M
150.32%10.53M
-99.42%564K
139.31%12.29M
175.43%10.06M
140.55%30.9M
-2.23%-20.93M
21,669.53%96.44M
44.33%-31.27M
---13.34M
Other non- operating income (expenses)
7.54%4.22M
-62.47%540K
0.48%1.05M
40.85%1.22M
145.47%1.41M
46.75%3.92M
102.11%1.44M
22.73%1.04M
12.13%869K
69.82%574K
Income before tax
-27.49%-45.58M
76.44%-10.41M
-122.68%-17.46M
75.02%-11.22M
72.51%-6.5M
69.32%-35.75M
-46.80%-44.19M
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
Income tax
-91.88%35K
431K
Net income
-26.07%-45.62M
76.59%-10.45M
-122.68%-17.46M
75.02%-11.22M
72.51%-6.5M
68.95%-36.18M
-48.23%-44.62M
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
Net income continuous Operations
-26.07%-45.62M
76.59%-10.45M
-122.68%-17.46M
75.02%-11.22M
72.51%-6.5M
68.95%-36.18M
-48.23%-44.62M
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
Minority interest income
Net income attributable to the parent company
-26.07%-45.62M
76.59%-10.45M
-122.68%-17.46M
75.02%-11.22M
72.51%-6.5M
68.95%-36.18M
-48.23%-44.62M
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
Preferred stock dividends
Other preferred stock dividends
-105.90%-1.33M
22.54M
Net income attributable to common stockholders
-26.07%-45.62M
68.55%-13.13M
-129.63%-16.13M
75.02%-11.22M
72.51%-6.5M
68.95%-36.18M
-38.66%-41.74M
649.45%54.43M
31.71%-44.91M
-119.37%-23.63M
Basic earnings per share
21.21%-0.52
87.34%-0.1
-120.00%-0.21
85.87%-0.13
87.69%-0.08
82.35%-0.66
-1,680.00%-0.79
418.18%1.05
66.42%-0.92
13.33%-0.65
Diluted earnings per share
21.21%-0.52
87.34%-0.1
25.00%-0.21
85.87%-0.13
87.69%-0.08
82.35%-0.66
-1,680.00%-0.79
15.15%-0.28
66.42%-0.92
13.33%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 17.96%83.25M-13.01%21.48M-7.02%19.07M70.55%24.73M65.28%17.96M64.13%70.58M138.89%24.7M83.16%20.51M40.06%14.5M-2.17%10.87M
Selling and administrative expenses -8.75%16.98M-41.00%3.99M2.78%4.1M1.39%4.46M28.16%4.43M46.70%18.61M106.91%6.77M22.13%3.99M39.42%4.4M15.42%3.46M
-General and administrative expense -8.75%16.98M-41.00%3.99M2.78%4.1M1.39%4.46M28.16%4.43M46.70%18.61M106.91%6.77M22.13%3.99M39.42%4.4M15.42%3.46M
Research and development costs 27.52%66.27M-2.44%17.49M-9.39%14.97M100.63%20.28M82.60%13.53M71.43%51.96M153.69%17.93M108.30%16.52M40.34%10.11M-8.67%7.41M
Operating profit -17.96%-83.25M13.01%-21.48M7.02%-19.07M-70.55%-24.73M-65.28%-17.96M-64.13%-70.58M-138.89%-24.7M-83.16%-20.51M-40.06%-14.5M2.17%-10.87M
Net non-operating interest income expense
Other net income (expense) 8.17%37.67M156.81%11.07M-98.35%1.61M144.46%13.52M189.87%11.47M147.36%34.82M1.37%-19.49M7,444.97%97.48M45.12%-30.41M-3,875.74%-12.76M
Gain on sale of security 8.25%33.45M150.32%10.53M-99.42%564K139.31%12.29M175.43%10.06M140.55%30.9M-2.23%-20.93M21,669.53%96.44M44.33%-31.27M---13.34M
Other non- operating income (expenses) 7.54%4.22M-62.47%540K0.48%1.05M40.85%1.22M145.47%1.41M46.75%3.92M102.11%1.44M22.73%1.04M12.13%869K69.82%574K
Income before tax -27.49%-45.58M76.44%-10.41M-122.68%-17.46M75.02%-11.22M72.51%-6.5M69.32%-35.75M-46.80%-44.19M877.01%76.97M31.71%-44.91M-119.37%-23.63M
Income tax -91.88%35K431K
Net income -26.07%-45.62M76.59%-10.45M-122.68%-17.46M75.02%-11.22M72.51%-6.5M68.95%-36.18M-48.23%-44.62M877.01%76.97M31.71%-44.91M-119.37%-23.63M
Net income continuous Operations -26.07%-45.62M76.59%-10.45M-122.68%-17.46M75.02%-11.22M72.51%-6.5M68.95%-36.18M-48.23%-44.62M877.01%76.97M31.71%-44.91M-119.37%-23.63M
Minority interest income
Net income attributable to the parent company -26.07%-45.62M76.59%-10.45M-122.68%-17.46M75.02%-11.22M72.51%-6.5M68.95%-36.18M-48.23%-44.62M877.01%76.97M31.71%-44.91M-119.37%-23.63M
Preferred stock dividends
Other preferred stock dividends -105.90%-1.33M22.54M
Net income attributable to common stockholders -26.07%-45.62M68.55%-13.13M-129.63%-16.13M75.02%-11.22M72.51%-6.5M68.95%-36.18M-38.66%-41.74M649.45%54.43M31.71%-44.91M-119.37%-23.63M
Basic earnings per share 21.21%-0.5287.34%-0.1-120.00%-0.2185.87%-0.1387.69%-0.0882.35%-0.66-1,680.00%-0.79418.18%1.0566.42%-0.9213.33%-0.65
Diluted earnings per share 21.21%-0.5287.34%-0.125.00%-0.2185.87%-0.1387.69%-0.0882.35%-0.66-1,680.00%-0.7915.15%-0.2866.42%-0.9213.33%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -